0000899243-23-004800.txt : 20230213
0000899243-23-004800.hdr.sgml : 20230213
20230213173531
ACCESSION NUMBER: 0000899243-23-004800
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230209
FILED AS OF DATE: 20230213
DATE AS OF CHANGE: 20230213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAPORTE KATHLEEN
CENTRAL INDEX KEY: 0001196201
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 23620297
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-09
0
0001785173
89bio, Inc.
ETNB
0001196201
LAPORTE KATHLEEN
C/O 89BIO, INC., 142 SANSOME
STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
1
0
0
0
Stock Option (Right to Buy)
14.70
2023-02-09
4
A
0
27400
0.00
A
2033-02-09
Common Stock
27400
27400
D
This option represents a right to purchase a total of 27,400 shares of the Issuer's Common Stock, which will vest in full on February 9, 2024, subject to the Reporting Person's continued service to the Issuer through such date.
/s/ Ryan A. Murr, as attorney-in-fact for Kathleen LaPorte
2023-02-13